Stellest™ Lenses Observational Multicentre European Study

This study evaluated the effectiveness of a new optical treatment for controlling myopia, using the Stellest lens, a device approved and marketed for myopia control in European children. The research focused on gathering data regarding the efficacy of this treatment in a European population. Researchers examined the impact of the Stellest lens on myopia progression and axial eye growth over a twelve-month period. Since the study involved a market-authorized device, it was observational rather than a clinical trial.